This Plain Language Summary of Publication article (PLSP) from Future Oncology, examined racial disparities in prostate cancer treatment by comparing care received by Black and White patients with advanced prostate cancer. The analysis focused on patients from two healthcare systems – Medicare and the Veterans Health Administration (VHA), including low-income Medicare patients who also had Medicaid coverage. The researchers specifically investigated whether patients received basic hormone therapy (ADT) alone or in combination with additional treatments like novel hormone therapy (NHT) or the chemotherapy drug docetaxel. Research has shown that combining ADT with these additional treatments can lead to longer survival compared to using ADT by itself.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer’ and was published in Prostate Cancer and Prostate Diseases.

Visit Nature using the link to read the original article.